The Food and Drug Administration has approved a treatment for gastroesphageal reflux disease made by a subsidiary of Mylan, the generic drug maker said Monday.
Indian drug maker Dr. Reddy’s Labs has launched a generic treatment for gastroesophageal reflux disease.